Drug Pricing Reform: Now It Is HHS Secretary Becerra’s Turn
Executive Summary
After months of reticence about his Administration's plans for tackling drug pricing, Biden's executive order offers some clues about what might be in store and what kind of timeline they are working with.
You may also be interested in...
Generic Drugs Outlined As ‘Significant Public Health Priority’ For FDA
The FDA Office of Generic Drugs has published its annual report, highlighting its contributions to the approval of Viatris’ generic cyclosporine rival to Restasis, alongside updates to bioequivalence standards and support for competition.
Another Drug Pricing Executive Order?!
President Joe Biden defines himself as the opposite of Donald Trump. But they appear to share a fondness for Executive Orders on drug pricing.
US Senators Urge PTO’s Vidal To Tackle Pharma Patent Thickets
A bipartisan group of senators has written to the US Patent and Trademark Office, urging it to tackle the impact of patent thickets on the generic and biosimilar drug industries.